Erin K. Brenner is Chief Product Dev. Officer of Pear Therapeutics, Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 Feb 23 | PEARQ Pear Therapeutics | RSU Class A Common Stock | Grant | Acquire A | No | No | 0 | 952,380 | 0.00 | 952,380 |
20 Jan 23 | PEARQ Pear Therapeutics | Class A Common Stock | Sell | Dispose S | No | No | 1.13 | 8,690 | 9.82 k | 43,310 |
14 Jan 23 | PEARQ Pear Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 0 | 22,000 | 0.00 | 52,000 |
14 Jan 23 | PEARQ Pear Therapeutics | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 22,000 | 0.00 | 44,667 |
9 Dec 22 | PEARQ Pear Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 1 | 15,000 | 15.00 k | 30,000 |
9 Dec 22 | PEARQ Pear Therapeutics | Stock Option Common Stock | Option exercise | Dispose M | No | No | 1 | 15,000 | 15.00 k | 90,234 |